Bal Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

BALPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+12.0%1-day move

₹64.56

prior close

₹68.63

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.0-0.1-0.1+12.0+18.6+18.2+16.9+16.6+19.3+18.0+18.0+32.3+18.0

Up moveDown movePending

AI summary

Bal Pharma Limited has submitted a compliance confirmation under SEBI (Depositories and Participants) Regulations, 2018. The filing confirms that details of securities dematerialized/rematerialized during the quarter ending 31.03.2026 were furnished to all stock exchanges within the prescribed time limit. The company further confirms that share certificates received for dematerialization were mutilated and cancelled after due verification, and the depository name was substituted as registered owner within 15 days of certificate receipt. The certificate was received from the company's R&T agent, MUFG Intime India Pvt Ltd. The filing is signed by Authorized Signatory Shailesh Siroya dated 06.04.2026.

Likely market impact

This is a routine regulatory compliance filing confirming proper handling of dematerialization requests. It carries no direct impact on the stock price or shareholder value as it does not involve any material corporate actions or financial changes.